Is gluten a cause of gastrointestinal symptoms in people without celiac disease?

Current Allergy and Asthma Reports

Volumn 13, Issue 6, 2013, Pages 631-638

  Biesiekierski, Jessica R ^a   Muir, Jane G ^a   Gibson, Peter R ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Celiac disease; Fodmaps; Food hypersensitivity; Gastrointestinal symptoms; Gluten sensitivity; Irritable bowel syndrome; Wheat

Indexed keywords

CARBOHYDRATE; GLUTEN; LECTIN; PROTEIN; WHEAT GERM AGGLUTININ;

ARTICLE; CELIAC DISEASE; FOOD ALLERGY; GASTROINTESTINAL SYMPTOM; GLUTEN FREE DIET; HLA TYPING; HUMAN; IN VITRO STUDY; INTESTINE BIOPSY; IRRITABLE COLON; NON CELIAC GLUTEN SENSITIVITY; SEROLOGY; WHEAT; WHEAT ALLERGY;

ANIMALS; CARBOHYDRATES; CELIAC DISEASE; DIET, GLUTEN-FREE; FOOD HYPERSENSITIVITY; GASTROINTESTINAL DISEASES; HUMANS; PLANT PROTEINS;

EID: 84890571871     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-013-0386-4     Document Type: Article

References (59)

1. Fry L. Dermatitis herpetiformis. In: Marsh M, editor. Coeliac disease. Oxford: Blackwell Scientific Publications; 1992.
2. Hadjivassiliou M, Grunewald RA, Davies-Jones GAB. Gluten sensitivity as a neurological illness. J Neurol Neurosurg Psychiatry. 2002;72(5):560-3.
3. Dickey W, Kearney N. Overweight in celiac disease: prevalence, clinical characteristics, and effect of a gluten-free diet. Am J Gastoenterol. 2006;101(10):2356-9.
4. Lucarelli S, Frediani T, Zingoni AM, Ferruzzi F, Giardini O, Quintieri F, et al. Food allergy and infantile autism. Panminerva Medica. 1995;37(3):137-41.
5. Hadley SK, Gaarder SM. Treatment of irritable bowel syndrome. Am Fam Physician. 2005;72(12):2501-6.
6. Wieser H. Chemistry of gluten proteins. Food Microbiol. 2007;24(2):115-9.
7. • Junker Y, Zeissig S, Kim SJ, Barisani D, Wieser H, Leffler DA, et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med. 2012;209(13):2395-408. Demonstration of a proinflammatory effect of a non-gluten protein in wheat.
8. • Eswaran S, Muir J, Chey WD. Fiber and functional gastrointestinal disorders. Am J Gastroenterol. 2013;108:718-27. Up-to-date review of fibre and its potential in symptom induction and therapy in functionial gastrointestinsl disorders.
9. Kelly G. Inulin-type prebiotics: a review. (Part 2). Altern Med Rev. 2009;14:36-55.
10. Gibson PR, Newnham E, Barrett JS, Shepherd SJ, Muir JG. Review article: fructose malabsorption and the bigger picture. Aliment Pharmacol Ther. 2007;25(4):349-63.
11. Barrett JS, Gearry RB, Muir JG, Irving PM, Rose R, Rosella O, et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther. 2010;31(8):874-82.
12. • Shepherd SJ, Lomer MC, Gibson PR. Short-chain carbohydrates and functional gastrointestinal disorders. Am JGastroenterol. 2013;108(5):707-17. Up-to-date review of short-chain carbohydrates on functional gastrointestinal disorders focussing mostly on fodmaps.
13. • Monash University Low FODMAP App (homepage on the internet). Melbourne, Monash University. Available from: http://www.med.monash.edu/cecs/ gastro/fodmap/iphone-app.html. Recently released app containing up-to-date listing of the fodmap content of foods as found on the Monash University database.
14. Biesiekierski JR, Rosella O, Rose R, Liels K, Barrett JS, Shepherd SJ, et al. Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals. J Hum Nutr Diet 2011;24(2):154-76. Demonstration that gluten-containing grains are rich in fructans and vice-versa.
15. • de Punder K, Pruimboom L. The dietary intake of wheat and other cereal grains and their role in inflammation. Nutritents. 2013;5:771-87. Useful review with particular reference to wheat germ agglutinin to remind that potentially pathogenic lectins are also present in wheat.
16. Quigley EM, Abdel-Hamid H, Barbara G, Bhatia SJ, Boeckxstaens G, De Giorgio R, et al. A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome. J Clin Gastroenterol. 2012;46:356-66.
17. Anonymous. Therapeutic Guidelines: Gastrointestinal Version 5, 2011, Therapeutic Guidelines Limited: Melbourne, Australia.
18. Catassi C, Anderson RP, Hill ID, Koletzko S, Lionetti E, Mouane N, Schumann M, Yachha SK. World perspective on celiac disease. J Pediatr Gastroenterol Nutr 2012;55(5):494-9.
19. Anderson RP, et al. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med. 2000;6(3):337-42.
20. Haines ML, Anderson RP, Gibson PR. Systematic review: the evidence base for long-term management of coeliac disease. Aliment Pharmacol Ther. 2008;28(9):1042-66.
21. • Kupfer SS, Jabri B. Pathophysiology of celiac disease. Gastrointest Endosc Clin N Am. 2012;22:639-60. Up-to-date review on developments in the pathogenesis of celaic disease in terms of genetics, immunology and environment.
22. Kagnoff MF. Two genetic loci control the murine immune response to A-gliadin, a wheat protein that activates coeliac sprue. Nature. 1982;296(5853):158-60.
23. Lundin KE, Scott H, Hansen T, Paulsen G, Halstensen TS, Fausa O, et al. Gliadin-specific, HLA-DQ(alpha 1*0501, beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med. 1993;178(1):187-96.
24. Lundin KE, Gjertsen HA, Scott H, Sollid LM, Thorsby E. T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol. 1994;41(4):285-91.
25. Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol. 2002;2(9):647-55.
26. Catassi C, Kryszak D, Bhatti B, Sturgeon C, Helzlsouer K, Clipp SL, et al. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med. 2010;42(7):530-8.
27. Holtmeier W, Caspary WF. Celiac disease. Orphanet J Rare Dis. 2006;1:3.
28. Sapone A, Bai JC, Ciacci C, Dolinsek J, Green PH, Hadjivassiliou M, et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med. 2012;10:13. Important international effort to provide consensus opinion on a classification of gluten-related disorders.
29. Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, Green PH, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62(1):43-52. Important international effort to define various issues in celiac disease.
30. http://www.bsg.org.uk/sections/small-bowel-nutrition-articles/ bsg-guidance-on-coeliac-disease-2010.html
31. Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R, et al. ESPGHAN Working Group on Coeliac Disease Diagnosis; ESPGHAN Gastroenterology Committee; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54(1):136-60.
32. Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656-76.
33. Bai JC, Fried M, Corazza GR, Schuppan D, Farthing M, Catassi C, et al. World gastroenterology organisation global guidelines on celiac disease. J Clin Gastroenterol. 2013;47(2):121-6.
34. Catassi C, Fabiani E, Iacono G, D'Agate C, Francavilla R, Biagi F, et al. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr. 2007;85(1):160-6.
35. Tanabe S. Analysis of food allergen structures and development of foods for allergic patients. Biosci Biotechnol Biochem. 2008;72(3):649-59.
36. Brandtzaeg P. Food allergy: separating the science from the mythology. Nat Rev Gastroenterol Hepatol. 2010;7(7):380-400.
37. Carroccio A, Mansueto P, Iacono G, Soresi M, D'Alcamo A, Cavataio F, et al. Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: exploring a new clinical entity. Am J Gastroenterol. 2012;107(12):1898-906. Provocative study suggesting that many patients with irritable bowel syndrome have wheat hypersensitivity, many having specific histopathological findings. The findings need to be reproduced at other centres.
38. Carroccio A, Brusca I, Mansueto P, Pirrone G, Barrale M, Di Prima L, et al. A cytologic assay for diagnosis of food hypersensitivity in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2010;8(3):254-60.
39. Carroccio A, Brusca I, Mansueto P, Soresi M, D'Alcamo A, Ambrosiano G, et al. Fecal assays detect hypersensitivity to cow's milk protein and gluten in adults with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2011;9(11):965-71.
40. • Carroccio A, Brusca I, Mansueto P, D'alcamo A, Barrale M, Soresi M, et al. A comparison between two different in vitro basophil activation tests for gluten- and cow's milk protein sensitivity in irritable bowel syndrome (IBS)-like patients. Clin Chem Lab Med. 2013;51(6):1257-63. Study confirming the potential value of the basophil activation test in identifying patients with wheat intolerance and irritable bowel syndrome.
41. Jones VA. Food intolerance: A major factor in the pathogenesis of irritable bowel syndrome. Lancet. 1982;2(8308):1115-7.
42. Dickerson JWT, Ballantine L, Hastrop K. Food allergy. Lancet. 1978;1(8061):773.
43. Ellis A, Linaker BD. Non-coeliac gluten sensitivity? Lancet. 1978;1(8061):1358.
44. Cooper BT, Holmes GK, Ferguson R, Thompson RA, Allan RN, Cooke WT Gluten-sensitive diarrhea without evidence of celiac disease. Gastroenterology. 1980;79:801-6.
45. Suter D, Fleming F. Cereal food allergy issues, opportunities and the way forward for industry. in 41st AIFST Convention. 2008. Sydney, Australia.
46. Vinning G,McMahon G. Gluten-free Grains. A demand-and-supply analysis of prospects for the Australian grains industry. Rural industries Research and Development Corporation: Canberra. 2006. 21(5): p. 359-65.
47. Sander GR, Cummins AG, Powell BC. Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins. FEBS Lett. 2005;579(21):4851-5.
48. Giovannini C, Sanchez M, Straface E, Scazzocchio B, Silano M, De Vincenzi M. Induction of apoptosis in Caco-2 cells by wheat gliadin peptides. Toxicology. 2000;145(1):63-71.
49. Hadjivassiliou M, Williamson CA, Woodroofe N. The immunology of gluten sensitivity: Beyond the gut. Trends Immunol. 2004;25(11):578-82.
50. Rivabene R, Mancini E, DeVincenzi M. In vitro cytotoxic effect of wheat gliadin-derived peptides on the Caco-2 intestinal cell line is associated with intracellular oxidative imbalance: implications for coeliac disease. Biochim Biophys Acta. 1999;1453:152-60.
51. Verdu EF, Huang X, Natividad J, Lu J, Blennerhassett PA, David CS, et al. Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice. Am J Physiol Gastrointest Liver Physiol. 2008;294(1):G217-25.
52. Wahnschaffe U, Ullrich R, Riecken EO, Schulzke JD. Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology. 2001;121:1329-38.
53. Wahnschaffe U, Schulzke JD, Zeitz M, Ullrich R. Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol. 2007;5(7):844-50.
54. Picarelli A, Maiuri L, Mazzilli MC, Coletta S, Ferrante P, Di Giovambattista F, et al. Gluten-sensitive disease with mild enteropathy. Gastroenterology. 1996;111:608-16.
55. Biesiekierski JR, Newnham ED, Irving PM, Barrett JS, Haines M, Doecke JD, et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol. 2011;106(3):508-14. The first randomised controlled parallel-group re-challenge trial of fodmap-deplete gluten in patients with self-perceived non-celiac gluten sensitivity showing gluten-specific induction of gastrointestinal symptoms and tiredness. Mechansism were not identified.
56. Sapone A, Lammers KM, Casolaro V, Cammarota M, Giuliano MT, De Rosa M, et al. Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: Celiac disease and gluten sensitivity. BMC Med. 2011;9:23.
57. Volta U, Tovoli F, Cicola R, Parisi C, Fabbri A, Piscaglia M, et al. Serological tests in gluten sensitivity (nonceliac gluten intolerance). J Clin Gastroenterol. 2012;46(8):680-5.
58. • Vazquez-Roque MI, Camilleri M, Smyrk T, Murray JA, Marietta E, O'Neill J, et al. A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology. 2013;144(5):903-11. Detailed study of gluten-containing and gluten-free diets in patients with diarrhea-predominant irrtiable bowel sydnrome, indicating that intestinal permeability is higher on the gluten-containing diet. However, the effect was not defined as gluten-specific.
59. Biesiekierski JR, Peters SL, Newnham ED, Rosella O, Muir JG, Gibson PR. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology. 2013;145(2):320-328. Cross-over, re-challenge study of fodmap-deplete gluten in patients with self-perceived non-celiac gluten sensitivity on a low fodmap background. Diets were rigorously controlled. While patients did improve on initial fodmap restriction, no gluten-specific effect on gastrointestinal symtpoms was identified.